| Type |
Details |
Score |
| Allele |
| Name: |
MYC binding protein; gene trap OST220957, Lexicon Genetics |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein; gene trap OST359643, Lexicon Genetics |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein; gene trap OST369921, Lexicon Genetics |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein; gene trap OST404115, Lexicon Genetics |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein; gene trap OST404116, Lexicon Genetics |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein; gene trap AA0029, Wellcome Trust Sanger Institute |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
myc target 1; gene trap b5p6c4, H Earl Ruley |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
myc target 1; targeted mutation 1a, Wellcome Trust Sanger Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
myc target 1; endonuclease-mediated mutation 1, Kyunghee Choi |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
myc target 1; targeted mutation 1.1, Cyagen Biosciences |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
myc target 1; endonuclease-mediated mutation 2, Cyagen Biosciences |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein; endonuclease-mediated mutation 1, Korea Mouse Phenotyping Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Arriaga JM |
| Year: |
2020 |
| Journal: |
Nat Cancer |
| Title: |
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance. |
| Volume: |
1 |
| Issue: |
11 |
| Pages: |
1082-1096 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mollaoglu G |
| Year: |
2017 |
| Journal: |
Cancer Cell |
| Title: |
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition. |
| Volume: |
31 |
| Issue: |
2 |
| Pages: |
270-285 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Quéva C |
| Year: |
1999 |
| Journal: |
Cell Growth Differ |
| Title: |
Dwarfism and dysregulated proliferation in mice overexpressing the MYC antagonist MAD1. |
| Volume: |
10 |
| Issue: |
12 |
| Pages: |
785-96 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hu MC |
| Year: |
2005 |
| Journal: |
Development |
| Title: |
Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. |
| Volume: |
132 |
| Issue: |
1 |
| Pages: |
215-25 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Osthus RC |
| Year: |
2005 |
| Journal: |
Cancer Res |
| Title: |
The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo. |
| Volume: |
65 |
| Issue: |
13 |
| Pages: |
5620-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Vincent-Fabert C |
| Year: |
2012 |
| Journal: |
Am J Pathol |
| Title: |
A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice. |
| Volume: |
180 |
| Issue: |
4 |
| Pages: |
1688-701 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jhan JR |
| Year: |
2016 |
| Journal: |
Oncotarget |
| Title: |
Stat3 accelerates Myc induced tumor formation while reducing growth rate in a mouse model of breast cancer. |
| Volume: |
7 |
| Issue: |
40 |
| Pages: |
65797-65807 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Takada I |
| Year: |
2022 |
| Journal: |
J Biol Chem |
| Title: |
Transcriptional coregulator Ess2 controls survival of post-thymic CD4(+) T cells through the Myc and IL-7 signaling pathways. |
| Volume: |
298 |
| Issue: |
9 |
| Pages: |
102342 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Dey S |
| Year: |
2020 |
| Journal: |
Mol Cancer Res |
| Title: |
miR-29a Is Repressed by MYC in Pancreatic Cancer and Its Restoration Drives Tumor-Suppressive Effects via Downregulation of LOXL2. |
| Volume: |
18 |
| Issue: |
2 |
| Pages: |
311-323 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Allen TD |
| Year: |
2011 |
| Journal: |
Cancer Res |
| Title: |
Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. |
| Volume: |
71 |
| Issue: |
18 |
| Pages: |
6010-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Boudreaux SP |
| Year: |
2012 |
| Journal: |
Oncogenesis |
| Title: |
Genome-wide profiling reveals transcriptional repression of MYC as a core component of NR4A tumor suppression in acute myeloid leukemia. |
| Volume: |
1 |
|
| Pages: |
e19 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Murach KA |
| Year: |
2022 |
| Journal: |
J Biol Chem |
| Title: |
Multi-transcriptome analysis following an acute skeletal muscle growth stimulus yields tools for discerning global and MYC regulatory networks. |
| Volume: |
298 |
| Issue: |
11 |
| Pages: |
102515 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Öztürk S |
| Year: |
2022 |
| Journal: |
Leukemia |
| Title: |
Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients. |
| Volume: |
36 |
| Issue: |
2 |
| Pages: |
464-475 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Colley SM |
| Year: |
1997 |
| Journal: |
Oncogene |
| Title: |
Increased transcription of the E mu-myc transgene and mRNA stabilisation produce only a modest elevation in Myc protein. |
| Volume: |
14 |
| Issue: |
22 |
| Pages: |
2735-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Frye M |
| Year: |
2003 |
| Journal: |
Development |
| Title: |
Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment. |
| Volume: |
130 |
| Issue: |
12 |
| Pages: |
2793-808 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Höglund A |
| Year: |
2011 |
| Journal: |
Cell Cycle |
| Title: |
Chk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibition. |
| Volume: |
10 |
| Issue: |
20 |
| Pages: |
3598-607 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Thege FI |
| Year: |
2022 |
| Journal: |
Cancer Res |
| Title: |
A Programmable In Vivo CRISPR Activation Model Elucidates the Oncogenic and Immunosuppressive Functions of MYC in Lung Adenocarcinoma. |
| Volume: |
82 |
| Issue: |
15 |
| Pages: |
2761-2776 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Giuriato S |
| Year: |
2006 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch. |
| Volume: |
103 |
| Issue: |
44 |
| Pages: |
16266-71 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liu T |
| Year: |
2007 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis. |
| Volume: |
104 |
| Issue: |
47 |
| Pages: |
18682-7 |
|
•
•
•
•
•
|
| Interaction Experiment |
| Description: |
The ciliary protein cystin forms a regulatory complex with necdin to modulate Myc expression. |
|
•
•
•
•
•
|
| Interaction Experiment |
| Description: |
Myc binds the pluripotency factor Utf1 through the basic-helix-loop-helix leucine zipper domain. |
|
•
•
•
•
•
|
| Interaction Experiment |
| Description: |
cBAF complex components and MYC cooperate early in CD8+ T cell fate. |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 164-4, Philip Leder |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Santoro A |
| Year: |
2019 |
| Journal: |
Cell Rep |
| Title: |
p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value. |
| Volume: |
26 |
| Issue: |
3 |
| Pages: |
624-638.e8 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
368
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
431
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
462
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
454
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
464
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
368
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
462
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
462
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1201966 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2020-03-20 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:3270125 |
| Pattern: |
Regionally restricted |
| Stage: |
TS25 |
| Assay Id: |
MGI:6400730 |
| Age: |
embryonic day 17.5 |
|
| Note: |
Expressed in a fraction of undifferentiated proliferating chondrocytes and overlapped with a subpopulation of Myc expressing cells. |
| Specimen Label: |
3E |
| Detected: |
true |
| Specimen Num: |
4 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Egler RA |
| Year: |
2005 |
| Journal: |
Oncogene |
| Title: |
Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1. |
| Volume: |
24 |
| Issue: |
54 |
| Pages: |
8038-50 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Leprince C |
| Year: |
1997 |
| Journal: |
J Biol Chem |
| Title: |
A new member of the amphiphysin family connecting endocytosis and signal transduction pathways. |
| Volume: |
272 |
| Issue: |
24 |
| Pages: |
15101-5 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lee E |
| Year: |
2002 |
| Journal: |
Science |
| Title: |
Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. |
| Volume: |
297 |
| Issue: |
5584 |
| Pages: |
1193-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Leprince C |
| Year: |
2003 |
| Journal: |
J Cell Sci |
| Title: |
Sorting nexin 4 and amphiphysin 2, a new partnership between endocytosis and intracellular trafficking. |
| Volume: |
116 |
| Issue: |
Pt 10 |
| Pages: |
1937-48 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Miyagawa T |
| Year: |
2016 |
| Journal: |
Hum Mol Genet |
| Title: |
BIN1 regulates BACE1 intracellular trafficking and amyloid-β production. |
| Volume: |
25 |
| Issue: |
14 |
| Pages: |
2948-2958 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Quéva C |
| Year: |
2001 |
| Journal: |
Mol Cell Biol |
| Title: |
Targeted deletion of the S-phase-specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis. |
| Volume: |
21 |
| Issue: |
3 |
| Pages: |
703-12 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Muto T |
| Year: |
2022 |
| Journal: |
Cell Stem Cell |
| Title: |
TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity. |
| Volume: |
29 |
| Issue: |
2 |
| Pages: |
298-314.e9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Breuer M |
| Year: |
1991 |
| Journal: |
Cancer Res |
| Title: |
Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras. |
| Volume: |
51 |
| Issue: |
3 |
| Pages: |
958-63 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Harris AW |
| Year: |
1997 |
| Journal: |
Curr Top Microbiol Immunol |
| Title: |
Lymphomas and plasmacytomas in transgenic mice involving bcl2, myc and v-abl. |
| Volume: |
224 |
|
| Pages: |
221-30 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Xiao D |
| Year: |
2016 |
| Journal: |
Mol Cell |
| Title: |
Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival. |
| Volume: |
64 |
| Issue: |
3 |
| Pages: |
493-506 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Riu E |
| Year: |
1996 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Prevention of diabetic alterations in transgenic mice overexpressing Myc in the liver. |
| Volume: |
93 |
| Issue: |
5 |
| Pages: |
2198-202 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Threadgill DW |
| Year: |
1990 |
| Journal: |
Cytogenet Cell Genet |
| Title: |
The thyroglobulin gene is syntenic with the MYC and MOS protooncogenes and carbonic anhydrase II and maps to chromosome 14 in cattle. |
| Volume: |
53 |
| Issue: |
1 |
| Pages: |
32-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Elliott RW |
| Year: |
1986 |
| Journal: |
Mouse News Lett |
| Title: |
A mouse "minisatellite". |
| Volume: |
74 |
|
| Pages: |
115-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Holland S |
| Year: |
2011 |
| Journal: |
J Biol Chem |
| Title: |
The ubiquitin ligase MYCBP2 regulates transient receptor potential vanilloid receptor 1 (TRPV1) internalization through inhibition of p38 MAPK signaling. |
| Volume: |
286 |
| Issue: |
5 |
| Pages: |
3671-80 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Stewart M |
| Year: |
1997 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. |
| Volume: |
94 |
| Issue: |
16 |
| Pages: |
8646-51 |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion, Philip Leder |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Harafuji N |
| Year: |
2023 |
| Journal: |
Front Cell Dev Biol |
| Title: |
Differential regulation of MYC expression by PKHD1/Pkhd1 in human and mouse kidneys: phenotypic implications for recessive polycystic kidney disease. |
| Volume: |
11 |
|
| Pages: |
1270980 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jäger R |
| Year: |
1997 |
| Journal: |
Oncogene |
| Title: |
Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. |
| Volume: |
15 |
| Issue: |
15 |
| Pages: |
1787-95 |
|
•
•
•
•
•
|
| Regulatory Region |
| Type: |
enhancer |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Regulatory Region |
| Type: |
enhancer |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Baumbach WR |
| Year: |
1988 |
| Journal: |
J Virol |
| Title: |
Integration of the BALB/c ecotropic provirus into the colony-stimulating factor-1 growth factor locus in a myc retrovirus-induced murine monocyte tumor. |
| Volume: |
62 |
| Issue: |
9 |
| Pages: |
3151-5 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Schmidt T |
| Year: |
1998 |
| Journal: |
Oncogene |
| Title: |
Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis. |
| Volume: |
17 |
| Issue: |
20 |
| Pages: |
2661-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Silva S |
| Year: |
2005 |
| Journal: |
Genes Chromosomes Cancer |
| Title: |
Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations. |
| Volume: |
42 |
| Issue: |
4 |
| Pages: |
416-26 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chen J |
| Year: |
2022 |
| Journal: |
Oncogene |
| Title: |
Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium. |
| Volume: |
41 |
| Issue: |
1 |
| Pages: |
138-145 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yang K |
| Year: |
2023 |
| Journal: |
Cell Death Differ |
| Title: |
Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer. |
|
|
| Pages: |
1-17 |
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein 2, E3 ubiquitin protein ligase; targeted mutation 1, Aaron DiAntonio |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein 2, E3 ubiquitin protein ligase; targeted mutation 1.1, Aaron DiAntonio |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein 2, E3 ubiquitin protein ligase; Magellum splicing defective |
| Allele Type: |
Chemically induced (ENU) |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein 2, E3 ubiquitin protein ligase; mutation 274-4, Timothy P O'Brien |
| Allele Type: |
Chemically induced (ENU) |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein 2, E3 ubiquitin protein ligase; gene trap CSI367, BayGenomics |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein 2, E3 ubiquitin protein ligase; gene trap XC692, BayGenomics |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein 2, E3 ubiquitin protein ligase; gene trap RRT219, BayGenomics |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein 2, E3 ubiquitin protein ligase; targeted mutation 1.1, Klaus Scholich |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein 2, E3 ubiquitin protein ligase; mutation 7 David R Beier |
| Allele Type: |
Chemically induced (ENU) |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
myc target 1; endonuclease-mediated mutation 1, Mouse Biology Program, UC Davis |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein 2, E3 ubiquitin protein ligase; endonuclease-mediated mutation 1, Cyagen Biosciences |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Allele |
| Name: |
MYC binding protein 2, E3 ubiquitin protein ligase; endonuclease-mediated mutation 2, Cyagen Biosciences |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Myct1/Myct1 |
| Background: |
involves: C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Edmondson DG |
| Year: |
1989 |
| Journal: |
Genes Dev |
| Title: |
A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. |
| Volume: |
3 |
| Issue: |
5 |
| Pages: |
628-40 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yu D |
| Year: |
2002 |
| Journal: |
Oncogene |
| Title: |
A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis. |
| Volume: |
21 |
| Issue: |
12 |
| Pages: |
1922-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lewcock JW |
| Year: |
2007 |
| Journal: |
Neuron |
| Title: |
The ubiquitin ligase Phr1 regulates axon outgrowth through modulation of microtubule dynamics. |
| Volume: |
56 |
| Issue: |
4 |
| Pages: |
604-20 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Raffeiner P |
| Year: |
2017 |
| Journal: |
Oncotarget |
| Title: |
Calcium-dependent binding of Myc to calmodulin. |
| Volume: |
8 |
| Issue: |
2 |
| Pages: |
3327-3343 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hagarman JA |
| Year: |
2009 |
| Journal: |
Genesis |
| Title: |
An essential gene mutagenesis screen across the highly conserved piebald deletion region of mouse chromosome 14. |
| Volume: |
47 |
| Issue: |
6 |
| Pages: |
392-403 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
4749
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yuwanita I |
| Year: |
2015 |
| Journal: |
Oncotarget |
| Title: |
Increased metastasis with loss of E2F2 in Myc-driven tumors. |
| Volume: |
6 |
| Issue: |
35 |
| Pages: |
38210-24 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
154
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
4746
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
352
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Regulatory Region |
| Type: |
enhancer |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Regulatory Region |
| Type: |
enhancer |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Regulatory Region |
| Type: |
enhancer |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Suda Y |
| Year: |
1987 |
| Journal: |
EMBO J |
| Title: |
Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice. |
| Volume: |
6 |
| Issue: |
13 |
| Pages: |
4055-65 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Takahashi K |
| Year: |
2006 |
| Journal: |
Cell |
| Title: |
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. |
| Volume: |
126 |
| Issue: |
4 |
| Pages: |
663-76 |
|
•
•
•
•
•
|